Ju H. Shim

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 210 publications

Clinical features, treatment patterns, and outcomes of young-onset hepatocellular carcinoma: a tertiary cohort analysis with a nationwide population-based study.

Clinical features, treatment patterns, and outcomes of young-onset hepatocellular carcinoma: a tertiary cohort analysis with a nationwide population-based study.

Journal: Journal of liver cancer

Published: May 27, 2026

Non-Selective Beta-Blocker Use Is Associated With Lower Mortality After Decompensation in Cirrhosis: A Nationwide Target Trial Emulation.

Non-Selective Beta-Blocker Use Is Associated With Lower Mortality After Decompensation in Cirrhosis: A Nationwide Target Trial Emulation.

Journal: Alimentary pharmacology & therapeutics

Published: May 11, 2026

Multicentre prospective trial of abbreviated MRI using gadoxetic acid versus CT for detection of late recurrent HCC (AMRICT): study protocol.

Multicentre prospective trial of abbreviated MRI using gadoxetic acid versus CT for detection of late recurrent HCC (AMRICT): study protocol.

Journal: BMJ open

Published: April 24, 2026

Prognostic Significance of Intraindividual CT and MRI LI-RADS Agreement and Discordance in Hepatocellular Carcinoma.

Prognostic Significance of Intraindividual CT and MRI LI-RADS Agreement and Discordance in Hepatocellular Carcinoma.

Journal: Radiology. Imaging cancer

Published: March 27, 2026

MRI-based Risk Scoring System to Predict Early Recurrence after Resection of Solitary Hepatocellular Carcinoma 5 cm or Smaller.

MRI-based Risk Scoring System to Predict Early Recurrence after Resection of Solitary Hepatocellular Carcinoma 5 cm or Smaller.

Journal: Radiology

Published: March 10, 2026

Long-term Outcomes of Anti-migration Fully Covered Metal Stents for Dominant Pancreatic Duct Strictures in Children: A Comparative Analysis with Adults.

Long-term Outcomes of Anti-migration Fully Covered Metal Stents for Dominant Pancreatic Duct Strictures in Children: A Comparative Analysis with Adults.

Journal: Gastrointestinal endoscopy

Published: February 09, 2026

Neoadjuvant Danburstotug (IMC-001) therapy in gastric, esophageal, and hepatocellular carcinoma: the NeoChance phase II study.

Neoadjuvant Danburstotug (IMC-001) therapy in gastric, esophageal, and hepatocellular carcinoma: the NeoChance phase II study.

Journal: NPJ precision oncology

Published: January 24, 2026

Pain, analgesic use and misconceptions in patients with hepatocellular carcinoma: a cross-sectional survey.

Pain, analgesic use and misconceptions in patients with hepatocellular carcinoma: a cross-sectional survey.

Journal: Journal of liver cancer

Published: January 15, 2026

Clinical predictors of response to Atezolizumab-bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.

Clinical predictors of response to Atezolizumab-bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.

Journal: JHEP reports : innovation in hepatology

Published: December 29, 2025

Clinical predictors of response to atezolizumab/bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.

Clinical predictors of response to atezolizumab/bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.

Journal: JHEP reports : innovation in hepatology

Published: December 29, 2025

Long-term Survival and Cure Fraction in Patients with Advanced Hepatocellular Carcinoma under Immunotherapy in Randomized Controlled Trials and Real-world Data.

Long-term Survival and Cure Fraction in Patients with Advanced Hepatocellular Carcinoma under Immunotherapy in Randomized Controlled Trials and Real-world Data.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 27, 2025

Hepatic Resection versus Stereotactic Body Radiation Therapy as Initial Local Treatment for BCLC Stage 0 Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis.

Hepatic Resection versus Stereotactic Body Radiation Therapy as Initial Local Treatment for BCLC Stage 0 Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis.

Journal: Liver cancer

Published: December 23, 2025

Showing 1-12 of 210

Last Updated: 09/26/2026